HELIXMITH - Trademark Details
Status: 700 - Registered
Serial Number
88166343
Registration Number
5906698
Word Mark
HELIXMITH
Status
700 - Registered
Status Date
2019-11-12
Filing Date
2018-10-23
Registration Number
5906698
Registration Date
2019-11-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-05-28
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
MAI, TINA HSIN
Statements
Certificate of Correction for Registration
In the statement, Column 1, line 1-3,"are deleted", and HELIXMITH CO., LTD (Korea, republic of Corporation) 1 Gwanak-ro 5th Fl. Bldg. 203, Seoul, Korea, South 08826 should be inserted
Goods and Services
reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugs, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicines for human purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; crude medicines, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer
Goods and Services
Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents, retail store services featuring biological preparations for medical use
Goods and Services
Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services
Pseudo Mark
HELIX MITH
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-11-05
Primary Code
005
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2018-11-05
Primary Code
035
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-11-05
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Connie L. Ellerbach
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2018-10-11 | 4020180139419 | South Korea | True |
| 2018-10-11 | 4020180139412018101 | South Korea | True |
| South Korea | True |
Trademark Events
| Event Date | Event Description |
| 2018-10-26 | NEW APPLICATION ENTERED IN TRAM |
| 2018-11-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-01-03 | ASSIGNED TO EXAMINER |
| 2019-01-05 | NON-FINAL ACTION WRITTEN |
| 2019-01-05 | NON-FINAL ACTION E-MAILED |
| 2019-01-05 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-03-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-03-08 | ASSIGNED TO LIE |
| 2019-03-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-03-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-03-22 | NON-FINAL ACTION WRITTEN |
| 2019-03-22 | NON-FINAL ACTION E-MAILED |
| 2019-03-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-03-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-03-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-03-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-04-03 | EXAMINERS AMENDMENT -WRITTEN |
| 2019-04-03 | EXAMINERS AMENDMENT E-MAILED |
| 2019-04-03 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2019-04-03 | EXAMINER'S AMENDMENT ENTERED |
| 2019-04-03 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-04-12 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 2019-04-22 | ELECTRONIC RECORD REVIEW COMPLETE |
| 2019-05-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-05-28 | PUBLISHED FOR OPPOSITION |
| 2019-05-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-06-11 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 2019-06-19 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2019-10-06 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 2019-11-12 | REGISTERED-PRINCIPAL REGISTER |
| 2019-12-03 | TEAS SECTION 7 REQUEST RECEIVED |
| 2020-01-21 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2020-01-21 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 2020-02-18 | OTQR WITHDRAWAL FROM PUBLICATION |
| 2020-02-18 | POST REGISTRATION ACTION CORRECTION |
| 2020-02-18 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2020-02-19 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| 2020-08-10 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 2020-08-25 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
